General Biologicals Corporation (TPEX:4117)

General Biologicals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	195.76	251.65	217.12	262.18	308.77	350.61
Short-Term Investments	-	-	-	88.9	60	122.99
Cash & Short-Term Investments	195.76	251.65	217.12	351.08	368.77	473.6
Cash Growth	-9.65%	15.90%	-38.16%	-4.80%	-22.13%	2001.14%
Accounts Receivable	55.12	96.69	84.36	57.18	42.31	57.61
Other Receivables	44.65	1.09	0.72	4.32	5.17	1.3
Receivables	99.78	97.78	85.09	61.5	47.49	58.91
Inventory	71.89	57.08	85.56	116.79	81.32	64.86
Prepaid Expenses	64.51	-	-	18.33	11.56	-
Other Current Assets	4.98	40.11	14.09	3.28	1.18	11.55
Total Current Assets	436.92	446.61	401.85	550.97	510.32	608.91
Property, Plant & Equipment	844.37	2,819	2,002	864.46	607.87	126.1
Long-Term Investments	30.81	40.45	38.16	36.68	38.52	9.8
Goodwill	21.61	21.61	20.68	20.68	20.68	44.05
Other Intangible Assets	30.9	32.71	36.19	41.09	44.58	18.53
Long-Term Deferred Tax Assets	-	-	-	11.93	18.91	13.8
Other Long-Term Assets	2,175	45.16	37.96	24.77	23.58	12.1
Total Assets	3,540	3,406	2,537	1,551	1,264	833.28
Accounts Payable	62.36	82.72	24.26	25.3	38.74	40.39
Accrued Expenses	14.07	15.11	18.51	12.2	12.95	12.56
Short-Term Debt	60	60	50	5	-	-
Current Portion of Long-Term Debt	65.14	41.04	1.59	1.57	3.24	7.33
Current Portion of Leases	10.59	107.67	117.73	10.1	7.75	6.61
Current Unearned Revenue	89.96	95.36	6.48	5.82	3.83	7.16
Other Current Liabilities	28.12	48.89	810.73	38.05	10.56	11.33
Total Current Liabilities	330.24	450.79	1,029	98.04	77.07	85.37
Long-Term Debt	1,982	1,697	33.54	0.13	1.71	1.67
Long-Term Leases	396.55	404.2	345.6	452.02	436.74	49.14
Long-Term Unearned Revenue	607.88	556.26	620.7	-	-	-
Pension & Post-Retirement Benefits	-	-	-	0.02	0.95	0.79
Long-Term Deferred Tax Liabilities	4.46	4.6	4.9	6.19	5.48	-
Other Long-Term Liabilities	62.18	6.65	6.65	301.11	7.84	8.57
Total Liabilities	3,383	3,119	2,041	857.51	529.79	145.54
Common Stock	608.25	608.25	598.25	598.25	598.25	598.25
Additional Paid-In Capital	99.28	99.28	87.8	87.8	87.8	404.16
Retained Earnings	-557.19	-428.4	-207.03	-8.23	44.05	-316.36
Comprehensive Income & Other	5.91	5.46	16.12	12.71	1.42	-1.5
Total Common Equity	156.24	284.59	495.13	690.52	731.51	684.55
Minority Interest	0.66	1.9	1.51	2.55	3.14	3.2
Shareholders' Equity	156.9	286.48	496.65	693.07	734.66	687.74
Total Liabilities & Equity	3,540	3,406	2,537	1,551	1,264	833.28
Total Debt	2,514	2,310	548.46	468.82	449.44	64.75
Net Cash (Debt)	-2,318	-2,058	-331.34	-117.74	-80.66	408.85
Net Cash Per Share	-38.75	-34.40	-5.54	-1.97	-1.35	7.74
Filing Date Shares Outstanding	60.83	60.83	59.83	59.83	59.83	59.83
Total Common Shares Outstanding	60.83	60.83	59.83	59.83	59.83	59.83
Working Capital	106.69	-4.19	-627.45	452.94	433.25	523.54
Book Value Per Share	2.57	4.68	8.28	11.54	12.23	11.44
Tangible Book Value	103.73	230.26	438.27	628.76	666.26	621.96
Tangible Book Value Per Share	1.71	3.79	7.33	10.51	11.14	10.40
Buildings	472.98	50.02	50.02	49.85	49.86	50.81
Machinery	195.37	194.1	189.38	174.16	171.07	168.63
Construction In Progress	197.37	2,210	1,415	263.91	1.77	-
Leasehold Improvements	20.13	20.13	20.13	20.13	20.13	20.61

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.